Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN41474531
ISRCTN41474531
Completed
Not Applicable

Randomised, controlled, double-blind clinical study on the effect of a functional milk-product on metabolism of men with diagnosed metabolic syndrome

Humana GmbH (Germany)0 sites60 target enrollmentApril 30, 2007
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Humana GmbH (Germany)
Enrollment
60
Status
Completed
Last Updated
11 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 30, 2007
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional

Investigators

Sponsor
Humana GmbH (Germany)

Eligibility Criteria

Inclusion Criteria

  • •Men, 45\-70 years old, with a metabolic syndrome as defined by the International Diabetes Federation, 2006 (A new IDF worldwide definition of the metabolic syndrome: the rationale and the results \- Diabetes Voice, Vol. 50 Issue 3, 2005\)

Exclusion Criteria

  • •1\. Participation in a clinical study with a medicament or a medicinal product within the last 30 days or simultaneous participation in another clinical examination
  • •2\. Intake of nitrate and/or calcium antagonists and/or alpha\-blockers, which affect the blood pressure
  • •3\. Known metabolic or gastro\-intestinal diseases, which affects the absorption, metabolism or excretion of food or food component
  • •4\. Condition after operation of the gastro\-intestinal tract, which affect gastro\-intestinal motility
  • •5\. Hemoglobin \< 12 g/dL
  • •6\. Malfunction of blood coagulation or drugs, leading to malfunction of blood coagulating diabetes
  • •7\. Operation within the last 3 months, which still affects the current state of health
  • •8\. Illness of thyroid gland, which has metabolic and/or cardiovascular effect
  • •9\. Known hepatitis B, hepatitis C, HIV infection or chronic liver damage
  • •10\. Kidney insufficiency

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Effect of Functional milk product On the Metabolic Syndrome IIMetabolic syndromeNutritional, Metabolic, Endocrine
ISRCTN90960030Humana GmbH (Germany)240
Active, not recruiting
Phase 1
clinical study on the efficacy of infiltrative echo-guided therapy with hyaluronic acid (500-730 KDa) (HYALGAN®) versus saline solution in the conservative treatment of Achilles tendinopathy. Subjects will be randomly assigned to one of these two groups of treatment. Both evaluator and patients are unaware of the treatment assigned. In the open label extension, patients with persistent pain can receive a second cycle of Hyalgan.Achilles tendinopathyTherapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]
EUCTR2013-004117-40-ITFidia Farmaceutici SpA54
Active, not recruiting
Phase 1
ATVAC (Lactobacilli Therapeutic Vaccine study)Bacterial vaginosis (Nugent score 4 or above)Therapeutic area: Diseases [C] - Female diseases of the urinary and reproductive systems and pregancy complications [C13]
EUCTR2013-002918-12-HUAmvac Kft
Recruiting
Phase 4
A randomized double-blind controlled clinical study on the effects of qishen yiqi dropping pills on exercise endurance and quality of life in patients with coronary heart disease after interventional therapy
ITMCTR2100004678China-Japan Friendship Hospital
Not yet recruiting
Phase 1
A randomized double-blind controlled clinical study of Qiangxin compound in the treatment of type 2 cardiorenal syndrome under the hierarchical management mode of Integrated Chinese and Western Medicine
ITMCTR2000003812Traditional Chinese Medicine Hospital of Shanghai